Kidney Drug Finerenone Shows Promise Beyond Diabetic Patients in Major Studies
A trio of major clinical studies is reshaping how researchers think about a widely used kidney medication. Finerenone, a drug originally approved for patients with diabetic kidney disease, has demonstrated protective effects that extend far beyond its initial patient population.
Broader Applications Beyond Diabetes
The research found that finerenone may